Source / episode info

• **Episode:**292
• **Title:**Divine Intervention Episode 292 – NBME Endocarditis and Myocarditis (For Step 1-3).
• **Published:**2021-03-09
• Source:Episode page

One-liner

This episode provides a high-yield review of infective endocarditis, covering risk factors (IVDU, PVE), specific causative organisms (S. aureus, Enterococcus), and complications; and myocarditis, detailing viral/drug causes (Coxsackie B, Anthracyclines) and the clinical picture mimicking heart failure.

High-yield summary

• Endocarditis Workup: Always obtain blood cultures before starting antibiotics. The preferred imaging modality is Transesophageal Echocardiogram (TEE) due to superior sensitivity for visualizing vegetations compared to TTE.
• PVE Endocarditis: In patients with prosthetic valve endocarditis, the most common pathogen is Staphylococcus aureus, especially if the valve was placed less than 60 days ago (early PVE).
• Myocarditis vs MI: Myocarditis presents with a subacute timeline (weeks of symptoms) and heart failure signs (S3 gallop, orthopnea), whereas an acute myocardial infarction (MI) involves rapid onset chest pain.
• Drug-Induced Cardiomyopathy: Anthracyclines (Doxorubicin, Daunorubicin) and Trastuzumab can cause dilated cardiomyopathy; prophylaxis requires administering Dexrazoxane.
• Endocarditis Site Specificity: IV drug users typically develop endocarditis on the right side of the heart (tricuspid valve) because systemic venous blood drains to the right atrium.
• Colon Cancer Association: The presence of Staphylococcus bovis or Clostridium septicum in a patient with endocarditis mandates screening for underlying colorectal malignancy due to potential mucosal barrier breakdown and bacterial translocation.

Learning objectives

• Differentiate the clinical presentation and timeline of infective endocarditis versus myocarditis.
• Identify key risk factors for endocarditis (e.g., IVDU, PVE, prosthetic valves).
• Correlate specific causative organisms with their typical sources or patient populations (S. aureus in PVE; Enterococcus after GI procedures).
• Understand the mechanism and prophylaxis required for drug-induced cardiomyopathy (Anthracyclines -> Dexrazoxane).
• Interpret cardiac findings, such as the difference between a wedge-shaped infarct (septic emboli) and a mushroom-shaped aneurysm (mycotic aneurysm).